Warning letter
Avena Botanicals, Inc.: warning letter of Nov 3, 2014
FDA warning letter 435131 · New England District Office
Key facts
| Reference number | 435131 |
|---|---|
| Company | Avena Botanicals, Inc. |
| Subject | CGMP/Dietary Supplement/Adulterated/Misbranded |
| Issue date | Nov 3, 2014 |
| Posted date | Nov 3, 2014 |
| Issuing office | New England District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 101.36, 111, 111.70(a), 111.70(b)(1), 111.70(b)(2), 111.70(b)(3), 111.70(e), 111.205(a), 111.255(b), 111.260(b), 111.260(h), 111.260(j) and 8 more |
| Inspection city | Rockport |
| Inspection ZIP | 04856 |
| Inspection start date | May 22, 2014 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: